If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1956  M.D. Medical College of Taiwan University, Taipei, Taiwan, R.O.C
  • 1961  ECFMG (Examining Council for Foreign Medical Graduates)
  • 1955-1957 Intern and Fixed Intern in Surgery, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
  • 1957-1959 Intern; Resident; Chief Resident in Surgery, New England Hospital, Boston, Massachusetts
  • 1959-1960 Resident in Pathology,Quincy City Hospital, Quincy, Mass.
  • 1970 Maryland Medical License
  • Resident in Internal Medicine, George Washington University Hospital, Washington, D.C., Maryland
  • Virginia Medical License
  • Certification: Clinical Cytogenetics (American Board of Medical Genetics)
  • Specialist in Internal Medicine, The Board of Physician Quality Assurance of the State of Maryland
  • 1989-1991 Fellow in Medical Oncology. Washington Hospital Center, Washington, D.C.
  • Bona Fide Member, Taipei Medical Association(12965)
  • The Board of Medical Oncology of the Chinese Oncology Society (82014)
  • 2009 Honorary Doctor of Medicine, National Taiwan University, Taiwan

Experience

  • Vice Dean, College of Medical Science and Technology, Taipei Medical University
  • Superintendent, Taipei Cancer Center, Taipei Medical University
  • 2017.05- Director, Taiwan Oncology Society, R.O.C.
  • 2015.08- Director, Taiwan Lung Cancer Society, R.O.C.
  • 2014.10- Board Member, Development Center for Biotechnology (DCB)
  • 2014.06- Member of the Board of Supervisors, Taiwan Genomics and Genetic Society
  • 2014.06- Board Member, The MJ Health Research Foundation
  • 2013.08- Superintendent, Taipei Cancer Center, Taipei Medical University
  • 2013.04- Member, The Tang Prize Selection Committee, Academia Sinica
  • 2013.01- Board Member, National Health Research Institutes (NHRI)
  • 2012- Member, Certificate Approval Committee, Quality improvement of cancer service, BHP, Minstry of Health and Welfare (MOHW)
  • 2012- Member, Committee of Hepatitis and Liver Cancer Control and Prevention, MOHW
  • 2012- Member, Council Unit of Policy of Chinese Medicine Industries, Committee on Chinese Medicine and Pharmacy, MOHW
  • 2012- Member, Council Unit of Science and Technology, MOHW
  • 2012- Member, Honorary Doctorate Program Review Committee, Taipei Medical University
  • 2012- Member, United Biobank Management Committee, Taipei Medical University
  • 2011- Deputy member, Human Subject Research Ethics Committee, Academia Sinica
  • 2011- Chair Professor & Associate Dean, Medical Science & Technology College of Taipei Medical University
  • 2010- General Director, Cancer Research Center, Taipei Medical University
  • 2009- Honorary Vice Superintendent, Taipei Medical University-Shangho Hospital, MOHW
  • 2009- Adjunct Professor, Graduate Institute of Oncology, National Taiwan University
  • 2008- Distinguished Research Fellow, Taipei Veterans General Hospital, Taiwan
  • 2008- Physician, Hematology & Oncology, Taipei Medical University-Municipal Wan Fang Hospital
  • 1998- Member, Academic Review Committee Ministry of Education, Executive Yuan
  • 1997- Vice President, Formosa Cancer Foundation

Awards

  • 1968 Woman of the Year Award, ROC
  • 1972 Arthur Flemming Award, USA
  • 1972 Honor Award from Department of Health, Education and Welfare, USA
  • 1984 Academician, Academia Sinica, ROC
  • 1985 Member, Advisory Committee, Institute of Biomedical Sciences, Academia Sinica
  • 1985 Scientific Award & President, Chinese American Medical and Health Asso., USA
  • 1989 Scientific Award, Chinese American Medical Society of USA
  • 1989 Outstanding Scientific Award, Organization of Chinese Americans, USA
  • 1989 PHS Commendation Award, USA
  • 1990-1995 Advisory Member, Institute of Biomedical Sciences, Academia Sinica
  • 1991-2008 Honorary Consultant, Veterans General Hospital-Taipei
  • 1992-1994 Advisory Member, Institute of Zoology, Academia Sinica
  • 1993-1996 Honorary Consultant, National Taiwan University Hospital
  • 1993-1998 Advisory Member, Atomic Energy Council, Executive Yuan
  • 1994 Advisory Member, Institute of Molecular Biology, Academia Sinica
  • 1994-1998 Outstanding Scholarship Lecturer, Foundation for the Advanced Outstanding Scholarship
  • 1995 Review Member, Personnel Committee, National Health Research Institutes
  • 1995-1998 Advisory Member, AIDS Consultation Committee, Department of Health, Executive Yuan
  • 1995-1997 President, the Chinese Oncology Society
  • 1996-2007 Review Member, Recruitment and Advisory Committee, National Health Research Institutes
  • 1996-2007 Review Member, Recruitment and Advisory Committee, Biostatistic Research Division, National Health Research Institutes
  • 1996 Review Member, Yang Investigators’ Thesis Award, Academia Sinica
  • 1996 Review Member, Research Physicians Grant, Institute of Biomedical Sciences, Academia Sinica
  • 1996-1999 President, the Chinese Society of Genetics
  • 1996-2009 Adjunct Professor, Medical College, National Taiwan University
  • 1998-2001 President, The Chinese Society of Clinical Oncology,
  • 2001-2007 Jacqueline Whang-Peng Honorary Lecturer (彭汪嘉康榮譽獎座),National Tsing Hua University
  • 2004-2006 Councilor, the Central Cancer Control Meeting, Executive Yuan
  • 2007-2010 Chang-Chin Lecturer National Tsing Hua University
  • 2008 Award for 1st L’OREAL Women for Science, Taiwan
  • 2008 Distinguished Investigator, Emeritus, National Health Research Institutes
  • 2009 Honorary Doctor of Medicine, National Taiwan University
  • 2011 The 2011 Reach to Recovery International Health Professional Medal, UICC
  • 2015 COS Lifetime Achievement Award, the Chinese Oncology Society, R.O.C
  • 2015 Health Medal of the First Order, Ministry of Health and Welfare, R.O.C.

Research Interests

  • Hemato-oncology
  • Oncogenetics

Fingerprint Dive into the research topics where Jacqueline Whang-Peng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Cytogenetics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Chromosome Aberrations Medicine & Life Sciences
Chromosomes Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Cell Line Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2020

通過老藥新用來開發新的肝癌治療選擇(2/2)

Whang-Peng, J.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

奈米HEVnp於晚期大腸直腸癌患者的治療策略(1/3)

Whang-Peng, J.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

汪嘉康-107研究計畫績效獎

Whang-Peng, J.

8/1/187/31/20

Project: B - Project of TMUh - Other (Funded by TMU)

105年度第二期癌症研究計畫-臺北醫學大學

Yen, Y., Whang-Peng, J., Liu, L. & Chang, W.

1/1/1612/31/16

Project: A - Government Institutionc - Ministry of Health and Welfare

104年度「空中救護審核機制計畫」

Tsai, S., Whang-Peng, J., Liu, L., Chang, W., Ho, Y., Cheng, Y., Yeh, S., Chen, K., Sung, S., Hung, K., Chen, R., Chiou, H., Chen, C. & Li, Y.

1/1/153/31/16

Project: A - Government Institutionc - Ministry of Health and Welfare

Research Output 1962 2019

1 Citation (Scopus)

Corrigendum: Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

Chin, Y. T., He, Z. R., Chen, C. L., Chu, H. C., Ho, Y., Su, P. Y., Yang, Y. C. S. H., Wang, K., Shih, Y. J., Chen, Y. R., Pedersen, J. Z., Incerpi, S., Nana, A. W., Tang, H. Y., Lin, H. Y., Mousa, S. A., Davis, P. J. & Whang-Peng, J., Jan 1 2019, In : Frontiers in Endocrinology. 10, APR, 241.

Research output: Contribution to journalComment/debate

Open Access
Endocrinology
Integrins
Colorectal Neoplasms
corrigendum
tetraiodothyroacetic acid

Leptin-derived peptides block leptin-induced proliferation by reducing expression of pro-inflammatory genes in hepatocellular carcinoma cells

Ho, Y., Wang, S. H., Chen, Y. R., Li, Z. L., Chin, Y. T., Yang, Y. C. S. H., Wu, Y. H., Su, K. W., Chu, H. R., Chiu, H. C., Crawford, D. R., Shih, Y. J., Grasso, P., Tang, H. Y., Lin, H. Y., Davis, P. J., Whang-Peng, J. & Wang, K., Nov 1 2019, In : Food and Chemical Toxicology. 133, 110808.

Research output: Contribution to journalArticle

leptin (116-130)
hepatoma
Leptin
leptin
Hepatocellular Carcinoma

Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells

Lin, C. C., Chin, Y. T., Shih, Y. J., Chen, Y. R., Chung, Y. Y., Lin, C. Y., Hsiung, C. N., Whang-Peng, J., Lee, S. Y., Lin, H. Y., Davis, P. J. & Wang, K., Jan 1 2019, In : Journal of Dental Sciences.

Research output: Contribution to journalArticle

Open Access
Mouth Neoplasms
Thyroxine
Thyroid Hormones
Genes
Cell Cycle Checkpoints

Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status

Chin, Y-T., He, Z-R., Chen, C-L., Chu, H-C., Ho, Y., Su, P-Y., Yang, Y-C. S. H., Wang, K., Shih, Y-J., Chen, Y-R., Pedersen, J. Z., Incerpi, S., Nana, A. W., Tang, H-Y., Lin, H-Y., Mousa, S. A., Davis, P. J. & Whang-Peng, J., 2019, In : Frontiers in Endocrinology. 10, p. 130

Research output: Contribution to journalArticle

Integrins
Colorectal Neoplasms
HCT116 Cells
Neoplasms
HT29 Cells

Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells

Chen, Y. R., Chen, Y. S., Chin, Y. T., Li, Z. L., Shih, Y. J., Yang, Y. C. S. H., ChangOu, C. A., Su, P. Y., Wang, S. H., Wu, Y. H., Chiu, H. C., Lee, S. Y., Liu, L. F., Whang-Peng, J., Lin, H. Y., Mousa, S. A., Davis, P. J. & Wang, K., Oct 1 2019, In : Food and Chemical Toxicology. 132, 110693.

Research output: Contribution to journalArticle

L-thyroxine
Mouth Neoplasms
resveratrol
thyroid hormones
Thyroid Hormones